Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Dana-Farber Cancer Institute patent describes CDK inhibitors

Oct. 28, 2016

Eisai reports FGFR-4 inhibitors for liver cancer

Oct. 28, 2016

Gedeon Richter patents MCH1 receptor antagonists

Oct. 28, 2016

Shanghai Huilun Life Science & Technology patents PARP-1 inhibitors

Oct. 28, 2016

Merck & Co. develops FXIa and/or plasma kallikrein inhibitors

Oct. 27, 2016

Eli Lilly describes GOAT inhibitors

Oct. 27, 2016

Hangzhou Innogate Pharma discloses IDO-1 and/or TDO inhibitors

Oct. 27, 2016

Changzhou Longthera Pharmaceuticals patents CDK/cyclin D1 inhibitors

Oct. 27, 2016

Harvard College presents antibacterial agents

Oct. 26, 2016

Gilead Sciences develops HIV integrase inhibitors

Oct. 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...